Risk Assessment

NC-stat DPNCheck can improve the effectiveness of neuropathy detection programs and is ideal for:

  • Health Risk Assessment Service Providers for In-home Use
  • Clinic Based Health Risk Assessments

Why Use Nerve Conduction to Detect Diabetic Peripheral Neuropathy (DPN)?

The expected rate of neuropathy approaches 50%1 but is often missed with traditional detection methods such as monofilament testing2

  • Traditional detection tools (monofilament or tuning fork) detect only late stage neuropathy and have low sensitivity
  • Due to the subjective nature of these tests they are usually performed by physicians not staff
  • Compliance rates for the performance of these tests are typically poor
  • Sural nerve conduction detects DPN with high diagnostic sensitivity at all stages of severity

Benefits of Improved DPN Detection in a Managed Care Organization:

  • Accurately risk assess diabetes patients
  • Early diagnosis of DPN presents opportunities to intervene and reduce costs
  • Identify those patients with neuropathy that are at highest risk for neuropathy related complications such as foot ulcers, neuropathic pain, and falls - DPN related ulcers and amputations have 5 year mortality rates comparable to colon cancer and worse than other common cancers, click here to view mortality data  
  • Efficient and cost effective testing

DPNCheck Clinical Validation

The NC-stat DPNCheck has been clinically validated in numerous peer-reviewed journal publications and clinical conference presentations. Click here to view the complete list.

1. Dyck PJ, Kratz KM, Karnes JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort:The Rochester Diabetic Neuropathy Study. Neurology. Apr 1993;43(4):817-824.
2. Perkins, et al. Simple Screening tests for Peripheral Neuropathy in the Diabetes Clinic. Diabetes Care. 24: 250-256, 2001.